Jim, this last post of yours is so very wrong.
This is not a comment on DMX, Pennsaid or WF10, as you all know that I sold my DMX recently.
I still read most of the posts on this site, even though I admit to completely bypassing the chapters that Wolf writes each day. (sorry W, but I don't have time in my day for those novels of yours! How do you find time to write them?).
Jim, your last post contains some highlighted lines, such as:
<<< But when it comes to DMX, there are people who have $100,000 invested, and they don't even know how WF10 works! >>>
Am I to understand that you are genuinely surprised by this?
If I follow your logic, only doctors and biochemists would ever invest in a biotech such as DMX.
Allow me to paraphrase your sentence to show how ludicrous it is:
"But when it comes to Nortel, there are people who have $1,000,000 invested, and they don't even know how a digital router works!"
See what I mean.
I put it to you that most investors, when they place their "bet", don't give a rodent's rectum about how their company's products actually work on a molecular/atomic level.
They are concerned with larger things, such as fundamentals, management, debt, market potential, etc.
Jim, it appears that you are losing sight of the forest.
Take off the green cloak, put down the bow & arrow and step away from the trees for a day or two.
On a lighter note, DMX is back up to the level that I sold it at and I wish you all the best of luck with your horse.
S&P |
